1887

Journal of General Virology header logo

Volume 103, Issue 5

Characterization of a dynamic self-replicating mammalian expression vector based on the circular ssDNA genome of beak and feather disease virus Open Access

Abstract

nucleic expression technologies using DNA or mRNA offer several advantages for recombinant gene expression. Their inherent ability to generate natively expressed recombinant proteins and antigens allows these technologies to mimic foreign gene expression without infection. Furthermore, foreign nucleic acid fragments have an inherent ability to act as natural immune adjuvants and stimulate innate pathogen- and DNA damage-associated receptors that are responsible for activating pathogen-associated molecular pattern (PAMP) and DNA damage-associated molecular pattern (DAMP) signalling pathways. This makes nucleic-acid-based expression technologies attractive for a wide range of vaccine and oncolytic immunotherapeutic uses. Recently, RNA vaccines have demonstrated their efficacy in generating strong humoral and cellular immune responses for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). DNA vaccines, which are more stable and easier to manufacture, generate similar immune responses to RNA, but typically exhibit lower immunogenicity. Here we report on a novel method of constructing self-amplifying DNA expression vectors that have the potential to amplify and enhance gene/antigen expression at a cellular level by increasing per cell gene copy numbers, boost genomic adjuvating effects and mitigate through replication many of the problems faced by non-replicating vectors such as degradation, methylation and gene silencing. These vectors employ a viral origin rolling circle replication cycle in mammalian host cells that amplifies the vector and gene of interest (GOI) copy number, maintaining themselves as nuclear episomes. We show that these vectors maintain persistently elevated GOI expression levels at the cellular level and induce morphological cellular alterations synonymous with increased cellular stress.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): beak and feather disease virus , DNA expression vector , gene-expression amplification , replicative , rolling-circle replication , self-amplifying DNA , self-replicating DNA and vaccine
Funding
This study was supported by the:
  • School of Public Health and Family Medicine, University of Cape Town
    • Principle Award Recipient: WarrenR. J. de Moor
  • Poliomyelitis Research Foundation
    • Principle Award Recipient: WarrenR. J. de Moor
  • National Research Foundation
    • Principle Award Recipient: WarrenR. J. de Moor
© 2022 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001746
2022-05-20
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/103/5/jgv001746.html?itemId=/content/journal/jgv/10.1099/jgv.0.001746&mimeType=html&fmt=ahah

References

  1. Crank MC, Gordon IJ, Yamshchikov GV, Sitar S, Hu Z et al. Phase 1 study of pandemic H1 DNA vaccine in healthy adults. PLoS One 2015; 10:e0123969 [View Article] [PubMed]
     [Google Scholar]
  2. Grunwald T, Ulbert S. Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases. Clin Exp Vaccine Res 2015; 4:1–10 [View Article] [PubMed]
     [Google Scholar]
  3. Li L, Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines 2016; 15:313–329 [View Article] [PubMed]
     [Google Scholar]
  4. Jin X, Morgan C, Yu X, DeRosa S, Tomaras GD et al. Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials. Vaccine 2015; 33:2347–2353 [View Article] [PubMed]
     [Google Scholar]
  5. Dutton JL, Woo W-P, Chandra J, Xu Y, Li B et al. An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1. Hum Vaccin Immunother 2016; 12:3079–3088 [View Article] [PubMed]
     [Google Scholar]
  6. Sáez-Cirión A, Manel N. Immune responses to retroviruses. Annu Rev Immunol 2018; 36:193–220 [View Article] [PubMed]
     [Google Scholar]
  7. Crank MC, Gordon IJ, Yamshchikov GV, Sitar S, Hu Z et al. Phase 1 study of pandemic H1 DNA vaccine in healthy adults. PLoS One 2015; 10:e0123969 [View Article] [PubMed]
     [Google Scholar]
  8. Garrison AR, Shoemaker CJ, Golden JW, Fitzpatrick CJ, Suschak JJ et al. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. PLoS Negl Trop Dis 2017; 11:e0005908 [View Article] [PubMed]
     [Google Scholar]
  9. Grunwald T, Ulbert S. Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases. Clin Exp Vaccine Res 2015; 4:1–10 [View Article] [PubMed]
     [Google Scholar]
  10. Bai H, Lester GMS, Petishnok LC, Dean DA. Cytoplasmic transport and nuclear import of plasmid DNA. Biosci Rep 2017; 37:BSR20160616 [View Article] [PubMed]
     [Google Scholar]
  11. Motwani M, Pesiridis S, Fitzgerald KA. DNA sensing by the cGAS–STING pathway in health and disease. Nat Rev Genet 2019; 20:657–674 [View Article] [PubMed]
     [Google Scholar]
  12. Volkman HE, Cambier S, Gray EE, Stetson DB. cGAS is predominantly a nuclear protein. Immunology 2018 [View Article]
     [Google Scholar]
  13. Diner BA, Lum KK, Toettcher JE, Cristea IM, Racaniello VR. Viral DNA sensors IFI16 and cyclic GMP-AMP synthase possess distinct functions in regulating viral gene expression, immune defenses, and apoptotic responses during herpesvirus infection. mBio 2016; 7: [View Article]
     [Google Scholar]
  14. Georg P, Sander LE. Innate sensors that regulate vaccine responses. Curr Opin Immunol 2019; 59:31–41 [View Article] [PubMed]
     [Google Scholar]
  15. Regnard GL, Halley-Stott RP, Tanzer FL, Hitzeroth II, Rybicki EP. High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. Plant Biotechnol J 2010; 8:38–46 [View Article] [PubMed]
     [Google Scholar]
  16. Gillespie J, Juhan NM, DiCristina J, Key KF, Ramamoorthy S et al. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is genetically stable in vitro and in vivo. Vaccine 2008; 26:4231–4236 [View Article] [PubMed]
     [Google Scholar]
  17. Fenaux M, Opriessnig T, Halbur PG, Meng XJ. Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs. J Virol 2003; 77:11232–11243 [View Article] [PubMed]
     [Google Scholar]
  18. Knudsen ML, Ljungberg K, Tatoud R, Weber J, Esteban M et al. Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen. PLoS One 2015; 10:e0117042 [View Article] [PubMed]
     [Google Scholar]
  19. Regnard GL, de Moor WRJ, Hitzeroth II, Williamson A-L, Rybicki EP. Xenogenic rolling-circle replication of a synthetic beak and feather disease virus genomic clone in 293TT mammalian cells and Nicotiana benthamiana. J Gen Virol 2017; 98:2329–2338 [View Article] [PubMed]
     [Google Scholar]
  20. Ortiz-Catedral L, McInnes K, Hauber ME, Brunton DH. First report of beak and feather disease virus (BFDV) in wild Red-fronted Parakeets (Cyanoramphus novaezelandiae) in New Zealand. Emu - Austral Ornithology 2016; 109:244–247 [View Article]
     [Google Scholar]
  21. Niagro FD, Forsthoefel AN, Lawther RP, Kamalanathan L, Ritchie BW et al. Beak and feather disease virus and porcine circovirus genomes: intermediates between the geminiviruses and plant circoviruses. Arch Virol 1998; 143:1723–1744 [View Article] [PubMed]
     [Google Scholar]
  22. Bassami MR, Berryman D, Wilcox GE, Raidal SR. Psittacine beak and feather disease virus nucleotide sequence analysis and its relationship to porcine circovirus, plant circoviruses, and chicken anaemia virus. Virology 1998; 249:453–459 [View Article] [PubMed]
     [Google Scholar]
  23. Cheung AK. Rolling-circle replication of an animal circovirus genome in a theta-replicating bacterial plasmid in Escherichia coli. J Virol 2006; 80:8686–8694 [View Article] [PubMed]
     [Google Scholar]
  24. Cheung AK. Specific functions of the Rep and Rep׳ proteins of porcine circovirus during copy-release and rolling-circle DNA replication. Virology 2015; 481:43–50 [View Article] [PubMed]
     [Google Scholar]
  25. Shepherd DN, Martin DP, Lefeuvre P, Monjane AL, Owor BE et al. A protocol for the rapid isolation of full geminivirus genomes from dried plant tissue. J Virol Methods 2008; 149:97–102 [View Article] [PubMed]
     [Google Scholar]
  26. Bassami MR, Berryman D, Wilcox GE, Raidal SR. Psittacine beak and feather disease virus nucleotide sequence analysis and its relationship to porcine circovirus, plant circoviruses, and chicken anaemia virus. Virology 1998; 249:453–459 [View Article] [PubMed]
     [Google Scholar]
  27. Cheung AK. Specific functions of the Rep and Rep proteins of porcine circovirus during copy-release and rolling-circle DNA replication. Virology 2015; 481:43–50 [View Article] [PubMed]
     [Google Scholar]
  28. Cheung AK. Porcine circovirus: transcription and DNA replication. Virus Res 2012; 164:46–53 [View Article] [PubMed]
     [Google Scholar]
  29. Finsterbusch T, Mankertz A. Porcine circoviruses--small but powerful. Virus Res 2009; 143:177–183 [View Article] [PubMed]
     [Google Scholar]
  30. Finsterbusch T, Steinfeldt T, Doberstein K, Rödner C, Mankertz A. Interaction of the replication proteins and the capsid protein of porcine circovirus type 1 and 2 with host proteins. Virology 2009; 386:122–131 [View Article] [PubMed]
     [Google Scholar]
  31. Ahuja D, Sáenz-Robles MT, Pipas JM. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 2005; 24:7729–7745 [View Article] [PubMed]
     [Google Scholar]
  32. Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol 2017; 17:97–111 [View Article] [PubMed]
     [Google Scholar]
  33. Li L, Petrovsky N, Li L, Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines 2016; 15:313–329 [View Article] [PubMed]
     [Google Scholar]
  34. Cheung AK. Porcine circovirus: Transcription and DNA replication. Virus Res 2012; 164:46–53 [View Article] [PubMed]
     [Google Scholar]
  35. Cheung AK. Specific functions of the Rep and Rep' proteins of porcine circovirus during copy-release and rolling-circle DNA replication. Virology 2015; 481:43–50 [View Article] [PubMed]
     [Google Scholar]
  36. Diner BA, Lum KK, Cristea IM. The emerging role of nuclear viral DNA sensors. J Biol Chem 2015; 290:26412–26421 [View Article] [PubMed]
     [Google Scholar]
  37. Vermaelen K. Vaccine strategies to improve anti-cancer cellular immune responses. Front Immunol 2019; 10:8 [View Article] [PubMed]
     [Google Scholar]
  38. Bednarski JJ, Sleckman BP. At the intersection of DNA damage and immune responses. Nat Rev Immunol 2019; 19:231–242 [View Article] [PubMed]
     [Google Scholar]
  39. Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2018; 25:486–541 [View Article]
     [Google Scholar]
  40. Bednarski JJ, Sleckman BP. At the intersection of DNA damage and immune responses. Nat Rev Immunol 2019; 19:231–242 [View Article] [PubMed]
     [Google Scholar]
  41. Faurez F, Dory D, Le Moigne V, Gravier R, Jestin A. Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection. Vaccine 2010; 28:3888–3895 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001746
Loading
Characterization of a dynamic self-replicating mammalian expression vector based on the circular ssDNA genome of beak and feather disease virus
J. Gen. Virol. 103, 001746 (2022); https://doi.org/10.1099/jgv.0.001746
/content/journal/jgv/10.1099/jgv.0.001746
/content/journal/jgv/10.1099/jgv.0.001746
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error